GlaxoSmithKline Intellectual Property Development Limited
发明人:
DENIS, Alexis,MIRGUET, Olivier,TOUM, Jérôme
申请号：
ES16823162
公开号：
ES2781550T3
申请日:
2016.10.25
申请国别(地区):
ES
年份:
2020
代理人:
摘要：
The present invention relates to the compound ((2R,2′R)-bis(((tetrahydro-2H-pyran-4-carbonyl)oxy)methyl) 1,1′-adipoylbis(pyrrolidine-2-carboxylate), pharmaceutical compositions comprising the same and the use of the same for treatment of diseases or disorders wherein depletion of serum amyloid P component (SAP) would be beneficial, including amyloidosis, Alzheimer's disease, type 2 diabetes mellitus and osteoarthritis.
